141 related articles for article (PubMed ID: 27318701)
21. Prognostic value of masticatory muscle involvement in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.
Kang M; Zhou P; Liao X; Xu M; Wang R
Oral Oncol; 2017 Dec; 75():100-105. PubMed ID: 29224805
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors in patients with nasopharyngeal carcinoma treated in Hospital Kuala Lumpur.
El-Sherbieny E; Rashwan H; Lubis SH; Choi VJ
Asian Pac J Cancer Prev; 2011; 12(7):1739-43. PubMed ID: 22126556
[TBL] [Abstract][Full Text] [Related]
23. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
[TBL] [Abstract][Full Text] [Related]
25. Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH/DCOG.
Buehrlen M; Zwaan CM; Granzen B; Lassay L; Deutz P; Vorwerk P; Staatz G; Gademann G; Christiansen H; Oldenburger F; Tamm M; Mertens R
Cancer; 2012 Oct; 118(19):4892-900. PubMed ID: 22359313
[TBL] [Abstract][Full Text] [Related]
26. Influence of endoscopic sinus surgery on the quality of life of patients with early nasopharyngeal carcinoma and the analysis of prognosis-related factors.
Si YF; Lan GP; Deng ZX; Weng JJ; Si JY; Qin YD; Huang B; Wang YL; Yang Y; Qin Y; Zhang BJ; Han X; Xiong WM
Tumour Biol; 2017 Jul; 39(7):1010428317707435. PubMed ID: 28714364
[TBL] [Abstract][Full Text] [Related]
27. Long-term survival of nasopharyngeal carcinoma patients with Stage II in intensity-modulated radiation therapy era.
Guo Q; Lu T; Lin S; Zong J; Chen Z; Cui X; Zhang Y; Pan J
Jpn J Clin Oncol; 2016 Mar; 46(3):241-7. PubMed ID: 26755831
[TBL] [Abstract][Full Text] [Related]
28. Clinical Outcome and Prognostic Factors of Intensity-Modulated Radiotherapy for T4 Stage Nasopharyngeal Carcinoma.
Luo Y; Gao Y; Yang G; Lang J
Biomed Res Int; 2016; 2016():4398498. PubMed ID: 27195286
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study.
Qiu WZ; Huang PY; Shi JL; Xia HQ; Zhao C; Cao KJ
Chin J Cancer; 2016 Jan; 35():2. PubMed ID: 26739148
[TBL] [Abstract][Full Text] [Related]
30. The Clinical Usefulness of (18)F-Fluorodeoxyglucose Positron Emission Tomography (PET) to Predict Oncologic Outcomes and PET-Based Radiotherapeutic Considerations in Locally Advanced Nasopharyngeal Carcinoma.
Yoon HI; Kim KH; Lee J; Roh YH; Yun M; Cho BC; Lee CG; Keum KC
Cancer Res Treat; 2016 Jul; 48(3):928-41. PubMed ID: 26693913
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of grading masticator space involvement in nasopharyngeal carcinoma according to MR imaging findings.
Zhang GY; Huang Y; Cai XY; Chen XP; Xu T; Wu J; Wei WH; Liu LZ; Huang ZL; Zhou MM; Xia ST; Wang YJ
Radiology; 2014 Oct; 273(1):136-43. PubMed ID: 24844470
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of the EGFR pathway in nasopharyngeal carcinoma: a systematic review and meta-analysis.
Ooft ML; Braunius WW; Heus P; Stegeman I; van Diest PJ; Grolman W; Zuur CI; Willems SM
Biomark Med; 2015; 9(10):997-1010. PubMed ID: 26441207
[TBL] [Abstract][Full Text] [Related]
33. Survival analysis of patients with advanced-stage nasopharyngeal carcinoma according to the Epstein-Barr virus status.
Peng H; Chen L; Zhang Y; Guo R; Li WF; Mao YP; Tan LL; Sun Y; Zhang F; Liu LZ; Tian L; Lin AH; Ma J
Oncotarget; 2016 Apr; 7(17):24208-16. PubMed ID: 27008701
[TBL] [Abstract][Full Text] [Related]
34. [Clinical efficacy of alternating chemo-radiotherapy for locally advanced nasopharyngeal carcinoma].
You X; Yang Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Mar; 28(6):376-80. PubMed ID: 24961123
[TBL] [Abstract][Full Text] [Related]
35. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
36. Treatment outcomes of patients with AJCC stage IVC nasopharyngeal carcinoma: benefits of primary radiotherapy.
Yeh SA; Tang Y; Lui CC; Huang EY
Jpn J Clin Oncol; 2006 Mar; 36(3):132-6. PubMed ID: 16520357
[TBL] [Abstract][Full Text] [Related]
37. A prospective protocol for nasopharyngeal carcinoma in children and adolescents: the Italian Rare Tumors in Pediatric Age (TREP) project.
Casanova M; Bisogno G; Gandola L; Cecchetto G; Di Cataldo A; Basso E; Indolfi P; D'Angelo P; Favini F; Collini P; Potepan P; Ferrari A;
Cancer; 2012 May; 118(10):2718-25. PubMed ID: 21918965
[TBL] [Abstract][Full Text] [Related]
38. Posterior cervical lymph node metastasis as the valuable prognostic factor for stage IVA/IVB nasopharyngeal carcinoma treated with induction chemotherapy followed by concurrent chemo-radiotherapy.
Thephamongkhol K; Setakornnukul J; Rojwatkarnjana S; Chansilpa Y
Int J Biol Markers; 2014 Dec; 29(4):e387-94. PubMed ID: 25198554
[TBL] [Abstract][Full Text] [Related]
39. A comparison between the Chinese 2008 and the 7th edition AJCC staging systems for nasopharyngeal carcinoma.
Pan J; Xu Y; Qiu S; Zong J; Guo Q; Zhang Y; Lin S; Lu JJ
Am J Clin Oncol; 2015 Apr; 38(2):189-96. PubMed ID: 23608833
[TBL] [Abstract][Full Text] [Related]
40. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]